Geode Capital Management
HZNP

Geode Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,360,567
Closed -$388M 4819
2023
Q3
$388M Buy
3,360,567
+83,026
+3% +$9.59M 0.05% 358
2023
Q2
$337M Buy
3,277,541
+98,488
+3% +$10.1M 0.04% 406
2023
Q1
$346M Buy
3,179,053
+105,252
+3% +$11.5M 0.05% 384
2022
Q4
$349M Buy
3,073,801
+54,463
+2% +$6.19M 0.05% 365
2022
Q3
$187M Buy
3,019,338
+23,963
+0.8% +$1.48M 0.03% 498
2022
Q2
$239M Sell
2,995,375
-17,320
-0.6% -$1.38M 0.04% 452
2022
Q1
$317M Buy
3,012,695
+107,397
+4% +$11.3M 0.04% 417
2021
Q4
$313M Buy
2,905,298
+90,703
+3% +$9.76M 0.04% 434
2021
Q3
$308M Buy
2,814,595
+6
+0% +$656 0.04% 419
2021
Q2
$263M Buy
2,814,589
+109,550
+4% +$10.2M 0.04% 444
2021
Q1
$249M Buy
2,705,039
+89,414
+3% +$8.22M 0.04% 439
2020
Q4
$191M Buy
2,615,625
+269,175
+11% +$19.7M 0.03% 474
2020
Q3
$182M Buy
2,346,450
+117,135
+5% +$9.1M 0.04% 431
2020
Q2
$124M Buy
2,229,315
+15,284
+0.7% +$849K 0.03% 506
2020
Q1
$65.6M Buy
2,214,031
+91,168
+4% +$2.7M 0.02% 639
2019
Q4
$76.8M Buy
2,122,863
+65,694
+3% +$2.38M 0.02% 720
2019
Q3
$56M Sell
2,057,169
-18,545
-0.9% -$505K 0.01% 823
2019
Q2
$49.9M Sell
2,075,714
-167,733
-7% -$4.04M 0.01% 870
2019
Q1
$59.3M Buy
2,243,447
+307,990
+16% +$8.14M 0.02% 752
2018
Q4
$37.8M Buy
1,935,457
+158,342
+9% +$3.09M 0.01% 872
2018
Q3
$34.8M Sell
1,777,115
-4,370
-0.2% -$85.6K 0.01% 1024
2018
Q2
$29.5M Buy
1,781,485
+158,118
+10% +$2.62M 0.01% 1079
2018
Q1
$23.1M Buy
1,623,367
+110,509
+7% +$1.57M 0.01% 1165
2017
Q4
$22.1M Buy
1,512,858
+23,950
+2% +$350K 0.01% 1196
2017
Q3
$18.9M Buy
1,488,908
+66,063
+5% +$838K 0.01% 1285
2017
Q2
$16.9M Buy
1,422,845
+43,264
+3% +$514K 0.01% 1320
2017
Q1
$20.4M Buy
1,379,581
+9,476
+0.7% +$140K 0.01% 1130
2016
Q4
$22.2M Buy
1,370,105
+171,361
+14% +$2.77M 0.01% 1009
2016
Q3
$21.7M Buy
1,198,744
+93,986
+9% +$1.7M 0.01% 945
2016
Q2
$18.2M Buy
1,104,758
+272,780
+33% +$4.49M 0.01% 1005
2016
Q1
$13.8K Buy
831,978
+28,835
+4% +$478 0.01% 1153
2015
Q4
$17.4M Buy
803,143
+34,054
+4% +$738K 0.01% 986
2015
Q3
$15.2M Buy
769,089
+4,398
+0.6% +$87.2K 0.01% 1056
2015
Q2
$26.6M Buy
764,691
+300,736
+65% +$10.4M 0.02% 771
2015
Q1
$12M Buy
463,955
+60,139
+15% +$1.56M 0.01% 1244
2014
Q4
$5.21M Buy
403,816
+43,073
+12% +$555K ﹤0.01% 1789
2014
Q3
$4.43M Buy
360,743
+20,348
+6% +$250K ﹤0.01% 1841
2014
Q2
$5.39M Buy
340,395
+18,455
+6% +$292K ﹤0.01% 1745
2014
Q1
$4.87M Buy
321,940
+89,810
+39% +$1.36M ﹤0.01% 1792
2013
Q4
$1.77M Buy
232,130
+27,044
+13% +$206K ﹤0.01% 2377
2013
Q3
$693K Buy
205,086
+37,972
+23% +$128K ﹤0.01% 2785
2013
Q2
$411K Buy
+167,114
New +$411K ﹤0.01% 2967